Financial Controller, DNA Script
Office located in Kremlin Bicêtre, Paris
Innovations in DNA synthesis for biological development
Open for applications
Innovations in DNA synthesis for biological development
201-500 employees
Open for applications
Office located in Kremlin Bicêtre, Paris
201-500 employees
Company mission
To accelerate breakthroughs in life science and human health.
Role
Who you are
- Having worked in companies undergoing a transition to profitability, demonstrating the ability to manage financial performance in a rapidly evolving business context, is a great asset
- Experience: Minimum of 4 years in finance or accounting roles within structured environments such as audit firms or large corporations. Experience in environments transitioning from loss-making to profitability is highly valued
- Language Proficiency: Fluency in both French and English is mandatory, as both languages are used on a daily basis within the Finance team, the Business and for Reporting purposes
- Education: Master's degree or equivalent in Finance, Accounting, or a related field
- Technical Skills: Proficiency in financial software and ERP systems; advanced knowledge of Microsoft Excel
- Soft Skills: Strong analytical abilities, business curiosity and entrepereurship spirit, proactive mindset with the ability to adapt to a rapidly changing environment
What the job involves
- This is an opportunity for a dynamic individual to join an international and highly skilled team, and to make significant contributions to commercializing a technology with far-reaching potential across the biological sciences and beyond
- As Financial Controller at DNA Script, you will oversee and manage the financial operations of our entities in both France and the United States in partnership with another Group Finance Controller
- Your prior experience in structured environments, such as audit firms or large corporations, coupled with a strong appetite for adventure and the ability to thrive in fast-paced settings will be key to make this role successful
- This role reports directly to the Director of Finance Operations & Controlling
- Financial Reporting: Prepare and review monthly, quarterly, and annual financial statements for both French and U.S. entities, ensuring accuracy and compliance with relevant accounting standards (e.g., IFRS, US GAAP)
- Budgeting and Forecasting: Develop and manage budgets, perform financial analysis, and provide forecasts to support strategic decision-making
- COGS Analysis & Inventory Control: Collaborate with supply chain and operations teams to track, analyze, and optimize Cost of Goods Sold (COGS), gross margins, and inventory valuation
- Compliance and Internal Controls: Ensure adherence to financial regulations and internal policies, implementing robust internal controls to safeguard company assets
- Cross-Functional Collaboration: Work closely with various departments, including R&D, Sales, and Operations, to provide financial insights and support business objectives
- Team Leadership: Supervise and mentor finance team members, fostering a culture of continuous improvement and professional development
- Audit Coordination: Contribute to external audits and liaise with auditors to ensure timely and accurate completion of audits
Our take
Outsourcing DNA synthesis can be a large problem for R&D labs, as unprecedented factors such as delivery delays or issues on arrival can lead to schedule alterations and material that is no longer suitable for use. DNA Script attempts to solve this issue by democratising DNA synthesis for laboratories everywhere.
DNA Script facilitates biological and scientific development through providing proprietary equipment to labs that facilitates in-house DNA synthesis. The equipment eliminates the need for a reliance on external sources, and can significantly speed up workflows and operational efficiencies.
An issue found with equipment is that the DNA synthesised may vary in quality across locations, a problem that the company is committed to addressing through investigations and evaluation. By increasing the ability of labs to carry out DNA synthesis, the possibilities of the tech are vast and have the potential for significant revolutionary scientific developments. 2022 funding has facilitated the advance of DNA Script's SYNTAX Platform, allowing scientists to print synthetic nucleic acids, avoiding the need for third-party waiting times.
Steph
Company Specialist at Welcome to the Jungle
Insights
14% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Jan 2022
$35m
SERIES C
Oct 2021
$165m
SERIES C
Total funding: $311.7m
Company HQ
Le Kremlin-Bicêtre, France
Leadership
Thomas Ybert
(CEO & Board Director)Previously a Metabolic Engineering Project Leader at Amyris and a Biotechnological Senior Scientist at TOTAL.
Xavier Godron
(CTO)Previously an Analyst at TOTAL and an Engineer at Akuo Energy.
Sylvain Gariel
(COO)Previously a Research Analyst at TOTAL, a Business Analyst at URGO, and a Mining Engineer for the French Ministry of Industry. Also worked as a Portfolio Manager for a state shareholding agency.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at DNA Script